Current List of Laboratories Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies, 1548-1550 [E6-96]
Download as PDF
<![CDATA[
1548
Federal Register / Vol. 71, No. 6 / Tuesday, January 10, 2006 / Notices
COMMUNITY LEVEL SURVEY BURDEN ESTIMATE—Continued
Number of respondents
Number of responses
Hourly burden/
response
Contextual Factors and Closing
Questions.
Intervention Specific Information and
Adaptations.
Intervention Outcomes .....................
Intervention Component Information
...........................................................
390
2
1.0
780
390
3
2.0
2,340
390
390
390
6
6
2
1.0
1.0
1.0
2,340
2,340
780
Total Community Level Year 3
Burden.
...........................................................
........................
24
7.9
10,062
Average Annual
Burden.
...........................................................
........................
21
8.1
8,827
Survey section
Content description
172–178 ............................................
Part II, 1–52 ......................................
53–60 ................................................
Sub-forms ..........................................
Review of past responses ................
Community
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 71–1044, One Choke Cherry
Road, Rockville, MD 20857. Written
comments should be received within 60
days of this notice.
Dated: December 30, 2005.
Anna Marsh,
Director, Office of Program Services.
[FR Doc. E6–95 Filed 1–9–06; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of Laboratories Which
Meet Minimum Standards To Engage in
Urine Drug Testing for Federal
Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
AGENCY:
wwhite on PROD1PC65 with NOTICES
ACTION:
Notice.
SUMMARY: The Department of Health and
Human Services (HHS) notifies Federal
agencies of the laboratories currently
certified to meet the standards of
Subpart C of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908),
on September 30, 1997 (62 FR 51118),
and on April 13, 2004 (69 FR 19644).
A notice listing all currently certified
laboratories is published in the Federal
Register during the first week of each
month. If any laboratory’s certification
is suspended or revoked, the laboratory
will be omitted from subsequent lists
until such time as it is restored to full
VerDate Aug<31>2005
16:09 Jan 09, 2006
Jkt 208001
certification under the Mandatory
Guidelines.
If any laboratory has withdrawn from
the HHS National Laboratory
Certification Program (NLCP) during the
past month, it will be listed at the end,
and will be omitted from the monthly
listing thereafter.
This notice is also available on the
Internet at https://workplace.samhsa.gov
and https://www.drugfreeworkplace.gov.
FOR FURTHER INFORMATION CONTACT: Mrs.
Giselle Hersh or Dr. Walter Vogl,
Division of Workplace Programs,
SAMHSA/CSAP, Room 2–1035, 1 Choke
Cherry Road, Rockville, Maryland
20857; 240–276–2600 (voice), 240–276–
2610 (fax).
SUPPLEMENTARY INFORMATION: The
Mandatory Guidelines were developed
in accordance with Executive Order
12564 and section 503 of Public Law
100–71. Subpart C of the Mandatory
Guidelines, ‘‘Certification of
Laboratories Engaged in Urine Drug
Testing for Federal Agencies,’’ sets strict
standards that laboratories must meet in
order to conduct drug and specimen
validity tests on urine specimens for
Federal agencies. To become certified,
an applicant laboratory must undergo
three rounds of performance testing plus
an on-site inspection. To maintain that
certification, a laboratory must
participate in a quarterly performance
testing program plus undergo periodic,
on-site inspections.
Laboratories which claim to be in the
applicant stage of certification are not to
be considered as meeting the minimum
requirements described in the HHS
Mandatory Guidelines. A laboratory
must have its letter of certification from
HHS/SAMHSA (formerly: HHS/NIDA)
which attests that it has met minimum
standards.
In accordance with Subpart C of the
Mandatory Guidelines dated April 13,
2004 (69 FR 19644), the following
laboratories meet the minimum
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Total hourly
burden
standards to conduct drug and specimen
validity tests on urine specimens:
ACL Laboratories, 8901 W. Lincoln
Ave., West Allis, WI 53227. 414–328–
7840/800–877–7016. (Formerly:
Bayshore Clinical Laboratory).
ACM Medical Laboratory, Inc., 160
Elmgrove Park, Rochester, NY 14624.
585–429–2264.
Advanced Toxicology Network, 3560
Air Center Cove, Suite 101, Memphis,
TN 38118. 901–794–5770/888–290–
1150.
Aegis Analytical Laboratories, Inc., 345
Hill Ave., Nashville, TN 37210. 615–
255–2400.
Baptist Medical Center-Toxicology
Laboratory, 9601 I–630, Exit 7, Little
Rock, AR 72205–7299. 501–202–2783.
(Formerly: Forensic Toxicology
Laboratory Baptist Medical Center).
Clinical Reference Lab, 8433 Quivira
Road, Lenexa, KS 66215–2802. 800–
445–6917.
Diagnostic Services, Inc., dba DSI,
12700 Westlinks Drive, Fort Myers,
FL 33913. 239–561–8200/800–735–
5416.
Doctors Laboratory, Inc., 2906 Julia
Drive, Valdosta, GA 31602. 229–671–
2281.
DrugScan, Inc., P.O. Box 2969, 1119
Mearns Road, Warminster, PA 18974.
215–674–9310.
Dynacare Kasper Medical Laboratories,*
10150–102 St., Suite 200, Edmonton,
Alberta, Canada T5J 5E2. 780–451–
3702/800–661–9876.
ElSohly Laboratories, Inc., 5 Industrial
Park Drive, Oxford, MS 38655. 662–
236–2609.
Express Analytical Labs, 3405 7th Ave.,
Suite 106, Marion, IA 52302. 319–
377–0500.
Gamma-Dynacare Medical
Laboratories,* A Division of the
Gamma-Dynacare, Laboratory
Partnership, 245 Pall Mall Street,
London, ONT, Canada N6A 1P4. 519–
679–1630.
E:\FR\FM\10JAN1.SGM
10JAN1
wwhite on PROD1PC65 with NOTICES
Federal Register / Vol. 71, No. 6 / Tuesday, January 10, 2006 / Notices
General Medical Laboratories, 36 South
Brooks St., Madison, WI 53715. 608–
267–6225.
Kroll Scientific Testing Laboratories,
Inc., 450 Southlake Blvd., Richmond,
VA 23236. 804–378–9130. (Formerly:
Scientific Testing Laboratories, Inc.)
Laboratory Corporation of America
Holdings, 7207 N. Gessner Road,
Houston, TX 77040. 713–856–8288/
800–800–2387.
Laboratory Corporation of America
Holdings, 69 First Ave., Raritan, NJ
08869. 908–526–2400/800–437–4986.
(Formerly: Roche Biomedical
Laboratories, Inc.)
Laboratory Corporation of America
Holdings, 1904 Alexander Drive,
Research Triangle Park, NC 27709.
919–572–6900/800–833–3984.
(Formerly: LabCorp Occupational
Testing Services, Inc., CompuChem
Laboratories, Inc.; CompuChem
Laboratories, Inc., A Subsidiary of
Roche Biomedical Laboratory; Roche
CompuChem Laboratories, Inc., A
Member of the Roche Group.)
Laboratory Corporation of America
Holdings, 10788 Roselle St., San
Diego, CA 92121. 800–882–7272.
(Formerly: Poisonlab, Inc.)
Laboratory Corporation of America
Holdings, 550 17th Ave., Suite 300,
Seattle, WA 98122. 206–923–7020/
800–898–0180. (Formerly: DrugProof,
Division of Dynacare/Laboratory of
Pathology, LLC; Laboratory of
Pathology of Seattle, Inc.; DrugProof,
Division of Laboratory of Pathology of
Seattle, Inc.)
Laboratory Corporation of America
Holdings, 1120 Main Street,
Southaven, MS 38671. 866–827–8042/
800–233–6339. (Formerly: LabCorp
Occupational Testing Services, Inc.;
MedExpress/National Laboratory
Center.)
Marshfield Laboratories, Forensic
Toxicology Laboratory, 1000 North
Oak Ave., Marshfield, WI 54449. 715–
389–3734/800–331–3734.
MAXXAM Analytics Inc.,* 6740
Campobello Road, Mississauga, ONT,
Canada L5N 2L8. 905–817–5700.
(Formerly: NOVAMANN (Ontario),
Inc.)
MedTox Laboratories, Inc., 402 W.
County Road D, St. Paul, MN 55112
651–636–7466/800–832–3244.
MetroLab-Legacy Laboratory Services,
1225 NE 2nd Ave., Portland, OR
97232. 503–413–5295/800–950–5295.
Minneapolis Veterans Affairs Medical
Center, Forensic Toxicology
Laboratory, 1 Veterans Drive,
Minneapolis, MN 55417. 612–725–
2088.
VerDate Aug<31>2005
16:09 Jan 09, 2006
Jkt 208001
National Toxicology Laboratories, Inc.,
1100 California Ave., Bakersfield, CA
93304. 661–322–4250/800–350–3515.
One Source Toxicology Laboratory, Inc.,
1213 Genoa-Red Bluff, Pasadena, TX
77504. 888–747–3774. (Formerly:
University of Texas Medical Branch,
Clinical Chemistry Division; UTMB
Pathology-Toxicology Laboratory.)
Oregon Medical Laboratories, P.O. Box
972, 722 East 11th Ave., Eugene, OR
97440–0972. 541–687–2134.
Pacific Toxicology Laboratories, 9348
DeSoto Ave., Chatsworth, CA 91311.
800–328–6942. (Formerly: Centinela
Hospital Airport Toxicology
Laboratory.)
Pathology Associates Medical
Laboratories, 110 West Cliff Dr.,
Spokane, WA 99204. 509–755–8991/
800–541–7897x7.
Physicians Reference Laboratory, 7800
West 110th St., Overland Park, KS
66210. 913–339–0372/800–821–3627.
Quest Diagnostics Incorporated, 3175
Presidential Dr., Atlanta, GA 30340.
770–452–1590/800–729–6432.
(Formerly: SmithKline Beecham
Clinical Laboratories; SmithKline BioScience Laboratories).
Quest Diagnostics Incorporated, 4770
Regent Blvd., Irving, TX 75063. 800–
824–6152. (Moved from the Dallas
location on 03/31/01; Formerly:
SmithKline Beecham Clinical
Laboratories; SmithKline Bio-Science
Laboratories).
Quest Diagnostics Incorporated, 4230
South Burnham Ave., Suite 250, Las
Vegas, NV 89119–5412. 702–733–
7866/800–433–2750. (Formerly:
Associated Pathologists Laboratories,
Inc.)
Quest Diagnostics Incorporated, 10101
Renner Blvd., Lenexa, KS 66219. 913–
888–3927/800–873–8845. (Formerly:
LabOne, Inc.; Center for Laboratory
Services, a Division of LabOne, Inc.)
Quest Diagnostics Incorporated, 400
Egypt Road, Norristown, PA 19403.
610–631–4600/877–642–2216.
(Formerly: SmithKline Beecham
Clinical Laboratories; SmithKline BioScience Laboratories).
Quest Diagnostics Incorporated, 506 E.
State Pkwy., Schaumburg, IL 60173.
800–669–6995/847–885–2010.
(Formerly: SmithKline Beecham
Clinical Laboratories; International
Toxicology Laboratories).
Quest Diagnostics Incorporated, 7600
Tyrone Ave., Van Nuys, CA 91405.
818–989–2520/800–877–2520.
(Formerly: SmithKline Beecham
Clinical Laboratories).
Quest Diagnostics Incorporated, 2282
South Presidents Drive, Suite C, West
Valley City, UT 84120. 801–606–
6301/800–322–3361. (Formerly:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
1549
Northwest Toxicology, a LabOne
Company; LabOne, Inc., dba
Northwest Toxicology; NWT Drug
Testing, NorthWest Toxicology, Inc.;
Northwest Drug Testing, a division of
NWT Inc.)
S.E.D. Medical Laboratories, 5601 Office
Blvd., Albuquerque, NM 87109, 505–
727–6300/800–999–5227.
South Bend Medical Foundation, Inc.,
530 N. Lafayette Blvd., South Bend,
IN 46601. 574–234–4176 x276.
Southwest Laboratories. 4645 E. Cotton
Center Boulevard, Suite 177, Phoenix,
AZ 85040. 602–438–8507/800–279–
0027.
Sparrow Health System, Toxicology
Testing Center, St. Lawrence Campus,
1210 W. Saginaw, Lansing, MI 48915.
517–364–7400. (Formerly: St.
Lawrence Hospital & Healthcare
System).
St. Anthony Hospital Toxicology
Laboratory, 1000 N. Lee St.,
Oklahoma City, OK 73101. 405–272–
7052.
Toxicology & Drug Monitoring
Laboratory, University of Missouri
Hospital & Clinics, 301 Business Loop
70 West, Suite 208, Columbia, MO
65203. 573–882–1273.
Toxicology Testing Service, Inc., 5426
N.W. 79th Ave., Miami, FL 33166.
305–593–2260.
US Army Forensic Toxicology Drug
Testing Laboratory, 2490 Wilson St.,
Fort George G. Meade, MD 20755–
5235. 301–677–7085.
*The Standards Council of Canada
(SCC) voted to end its Laboratory
Accreditation Program for Substance
Abuse (LAPSA) effective May 12, 1998.
Laboratories certified through that
program were accredited to conduct
forensic urine drug testing as required
by U.S. Department of Transportation
(DOT) regulations. As of that date, the
certification of those accredited
Canadian laboratories will continue
under DOT authority. The responsibility
for conducting quarterly performance
testing plus periodic on-site inspections
of those LAPSA-accredited laboratories
was transferred to the U.S. HHS, with
the HHS’ NLCP contractor continuing to
have an active role in the performance
testing and laboratory inspection
processes. Other Canadian laboratories
wishing to be considered for the NLCP
may apply directly to the NLCP
contractor just as U.S. laboratories do.
Upon finding a Canadian laboratory to
be qualified, HHS will recommend that
DOT certify the laboratory (Federal
Register, July 16, 1996) as meeting the
minimum standards of the Mandatory
Guidelines published in the Federal
Register on April 13, 2004 (69 FR
E:\FR\FM\10JAN1.SGM
10JAN1
1550
Federal Register / Vol. 71, No. 6 / Tuesday, January 10, 2006 / Notices
19644). After receiving DOT
certification, the laboratory will be
included in the monthly list of HHScertified laboratories and participate in
the NLCP certification maintenance
program.
Anna Marsh,
Director, Office Program Services, SAMHSA.
[FR Doc. E6–96 Filed 1–9–06; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
Endangered Species Recovery Permit
Application
Fish and Wildlife Service,
Interior.
ACTION: Notice of receipt of a permit
application.
wwhite on PROD1PC65 with NOTICES
AGENCY:
SUMMARY: The following applicant has
applied for an enhancement of
propagation or survival permit to
conduct certain activities with
endangered species pursuant to section
10(a)(1)(A) of the Endangered Species
Act. The U.S. Fish and Wildlife Service
(‘‘we’’) solicits review and comment
from local, State and Federal agencies,
and the public on the following permit
request.
DATES: Comments on this permit
application must be received on or
before February 9, 2006.
ADDRESSES: Written data or comments
should be submitted to the U.S. Fish
and Wildlife Service, Chief, Endangered
Species, Ecological Services, 911 NE.
11th Avenue, Portland, Oregon 97232–
4181 (fax: 503–231–6243). Please refer
to the permit number when submitting
comments. All comments received,
including names and addresses, will
become part of the official
administrative record and may be made
available to the public.
FOR FURTHER INFORMATION CONTACT:
Documents and other information
submitted with this application are
available for review, subject to the
requirements of the Privacy Act and
Freedom of Information Act, by any
party who submits a written request for
a copy of such documents within 30
days of the date of publication of this
notice to the address above (telephone:
503–231–2063). Please refer to the
permit number when requesting copies
of documents.
SUPPLEMENTARY INFORMATION:
Permit No. TE–114934
Applicant: Idaho Department of Fish
and Game, Boise, Idaho.
VerDate Aug<31>2005
16:09 Jan 09, 2006
Jkt 208001
The applicant requests a permit to
take (harass by survey, capture, handle,
collar, take blood samples, relocate,
sacrifice, and release) the gray wolf
(Canis lupus) in conjunction with wolf
management activities in the State of
Idaho north of Interstate 90, for the
purpose of enhancing its survival.
The applicant proposes to: (a)
Conduct monitoring of wolf
populations; and (b) coordinate nonlethal and lethal control actions to
reduce wolf conflicts with livestock and
dogs. These actions are currently
coordinated by the U.S. Fish and
Wildlife Service (Service). If the permit
is issued, the applicant would take on
responsibility for managing wolves in
northern Idaho. Wolf management
activities would be in accordance with
the requirements of the State of Idaho
Wolf Conservation and Management
Plan (March 2002) and the Service’s
Interim Wolf Control Plan for
Northwestern Montana and the
Panhandle of Northern Idaho (Control
Plan) (September 1999).
If issued, the permit would not affect
ongoing wolf management in the
remainder of the State of Idaho
conducted in accordance with the nonessential experimental population
regulations found at 50 CFR 17.84(n).
We have determined that a practical,
responsive management program is
essential to enhancing survival of the
wolf in the wild (Service 1987; Service
1994; Service 1999). The program must
respond to wolf-livestock conflicts,
while promoting wolf recovery
objectives. The Control Plan provides
guidelines for: (a) Determining problem
wolf status (including investigative
procedures and criteria), (b) conducting
wolf control actions, and (c) disposition
of problem wolves.
We have made a preliminary
determination that issuance of this
permit would be categorically excluded
from further consideration under the
National Environmental Policy Act of
1969 (NEPA). If issued, the permit
would authorize Idaho Department of
Fish and Game to manage wolves in the
same manner that the Service has in the
6 years since the Control Plan was
adopted for northern Idaho. No
additional environmental impacts
would be expected beyond those
analyzed in the Service’s 1988
Environmental Assessment, the
Service’s 1999 Environmental Action
Memorandum, and the Control Plan.
The effect of the permit would be to
allow continuation of previously
analyzed and authorized activities;
therefore, its issuance would be an
administrative action.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Our preliminary NEPA categorical
exclusion determination, the two wolf
plans noted above, and the Idaho
Department of Fish and Game permit
application, can be found at: https://
www.fws.gov/pacific/ecoservices/
endangered/recovery/default.htm.
Additional information about wolf
recovery and conservation in the
northwestern United States, including
control of problem wolves, can be found
in various reports at: https://
westerngraywolf.fws.gov/.
All comments received from
individuals become part of the official
public record. Requests for such
comments will be handled in
accordance with the Freedom of
Information Act and the Council on
Environmental Quality’s National
Environmental Protection Act
regulations [40 CFR 1506.6(f)]. Our
practice is to make comments, including
names and addresses of respondents,
available for public review during
regular business hours. Individual
respondents may request that we
withhold their home address from the
record, but this must be stated
prominently at the beginning of their
comments. We will honor these requests
to the extent allowable by law.
We solicit public review and
comment on this recovery permit
application.
Authority: This document is published
under the authority of the Endangered
Species Act of 1973, as amended (16 U.S.C.
1531 et seq.).
Dated: December 13, 2005.
David J. Wesley,
Acting Regional Director, Region 1, U.S. Fish
and Wildlife Service.
[FR Doc. E6–93 Filed 1–9–06; 8:45 am]
BILLING CODE 4310–55–P
DEPARTMENT OF THE INTERIOR
Bureau of Land Management
[NV–030–1610–DU]
Notice of Intent To Prepare an
Amendment to the Carson City Field
Office Consolidated Resource
Management Plan
Bureau of Land Management,
Interior.
ACTION: Notice of intent.
AGENCY:
SUMMARY: This document provides
notice that the Bureau of Land
Management (BLM) intends to prepare a
Resource Management Plan (RMP)
amendment to address Lands and Land
Tenure Issues, and Recreation and
Travel Management. The appropriate
state, tribal and local governments will
E:\FR\FM\10JAN1.SGM
10JAN1
]]>Agencies
[Federal Register Volume 71, Number 6 (Tuesday, January 10, 2006)]
[Notices]
[Pages 1548-1550]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-96]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Current List of Laboratories Which Meet Minimum Standards To
Engage in Urine Drug Testing for Federal Agencies
AGENCY: Substance Abuse and Mental Health Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) notifies
Federal agencies of the laboratories currently certified to meet the
standards of Subpart C of the Mandatory Guidelines for Federal
Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory
Guidelines were first published in the Federal Register on April 11,
1988 (53 FR 11970), and subsequently revised in the Federal Register on
June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on
April 13, 2004 (69 FR 19644).
A notice listing all currently certified laboratories is published
in the Federal Register during the first week of each month. If any
laboratory's certification is suspended or revoked, the laboratory will
be omitted from subsequent lists until such time as it is restored to
full certification under the Mandatory Guidelines.
If any laboratory has withdrawn from the HHS National Laboratory
Certification Program (NLCP) during the past month, it will be listed
at the end, and will be omitted from the monthly listing thereafter.
This notice is also available on the Internet at https://
workplace.samhsa.gov and https://www.drugfreeworkplace.gov.
FOR FURTHER INFORMATION CONTACT: Mrs. Giselle Hersh or Dr. Walter Vogl,
Division of Workplace Programs, SAMHSA/CSAP, Room 2-1035, 1 Choke
Cherry Road, Rockville, Maryland 20857; 240-276-2600 (voice), 240-276-
2610 (fax).
SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were developed in
accordance with Executive Order 12564 and section 503 of Public Law
100-71. Subpart C of the Mandatory Guidelines, ``Certification of
Laboratories Engaged in Urine Drug Testing for Federal Agencies,'' sets
strict standards that laboratories must meet in order to conduct drug
and specimen validity tests on urine specimens for Federal agencies. To
become certified, an applicant laboratory must undergo three rounds of
performance testing plus an on-site inspection. To maintain that
certification, a laboratory must participate in a quarterly performance
testing program plus undergo periodic, on-site inspections.
Laboratories which claim to be in the applicant stage of
certification are not to be considered as meeting the minimum
requirements described in the HHS Mandatory Guidelines. A laboratory
must have its letter of certification from HHS/SAMHSA (formerly: HHS/
NIDA) which attests that it has met minimum standards.
In accordance with Subpart C of the Mandatory Guidelines dated
April 13, 2004 (69 FR 19644), the following laboratories meet the
minimum standards to conduct drug and specimen validity tests on urine
specimens:
ACL Laboratories, 8901 W. Lincoln Ave., West Allis, WI 53227. 414-328-
7840/800-877-7016. (Formerly: Bayshore Clinical Laboratory).
ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624.
585-429-2264.
Advanced Toxicology Network, 3560 Air Center Cove, Suite 101, Memphis,
TN 38118. 901-794-5770/888-290-1150.
Aegis Analytical Laboratories, Inc., 345 Hill Ave., Nashville, TN
37210. 615-255-2400.
Baptist Medical Center-Toxicology Laboratory, 9601 I-630, Exit 7,
Little Rock, AR 72205-7299. 501-202-2783. (Formerly: Forensic
Toxicology Laboratory Baptist Medical Center).
Clinical Reference Lab, 8433 Quivira Road, Lenexa, KS 66215-2802. 800-
445-6917.
Diagnostic Services, Inc., dba DSI, 12700 Westlinks Drive, Fort Myers,
FL 33913. 239-561-8200/800-735-5416.
Doctors Laboratory, Inc., 2906 Julia Drive, Valdosta, GA 31602. 229-
671-2281.
DrugScan, Inc., P.O. Box 2969, 1119 Mearns Road, Warminster, PA 18974.
215-674-9310.
Dynacare Kasper Medical Laboratories,* 10150-102 St., Suite 200,
Edmonton, Alberta, Canada T5J 5E2. 780-451-3702/800-661-9876.
ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655.
662-236-2609.
Express Analytical Labs, 3405 7th Ave., Suite 106, Marion, IA 52302.
319-377-0500.
Gamma-Dynacare Medical Laboratories,* A Division of the Gamma-Dynacare,
Laboratory Partnership, 245 Pall Mall Street, London, ONT, Canada N6A
1P4. 519-679-1630.
[[Page 1549]]
General Medical Laboratories, 36 South Brooks St., Madison, WI 53715.
608-267-6225.
Kroll Scientific Testing Laboratories, Inc., 450 Southlake Blvd.,
Richmond, VA 23236. 804-378-9130. (Formerly: Scientific Testing
Laboratories, Inc.)
Laboratory Corporation of America Holdings, 7207 N. Gessner Road,
Houston, TX 77040. 713-856-8288/800-800-2387.
Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ
08869. 908-526-2400/800-437-4986. (Formerly: Roche Biomedical
Laboratories, Inc.)
Laboratory Corporation of America Holdings, 1904 Alexander Drive,
Research Triangle Park, NC 27709. 919-572-6900/800-833-3984. (Formerly:
LabCorp Occupational Testing Services, Inc., CompuChem Laboratories,
Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical
Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche
Group.)
Laboratory Corporation of America Holdings, 10788 Roselle St., San
Diego, CA 92121. 800-882-7272. (Formerly: Poisonlab, Inc.)
Laboratory Corporation of America Holdings, 550 17th Ave., Suite 300,
Seattle, WA 98122. 206-923-7020/800-898-0180. (Formerly: DrugProof,
Division of Dynacare/Laboratory of Pathology, LLC; Laboratory of
Pathology of Seattle, Inc.; DrugProof, Division of Laboratory of
Pathology of Seattle, Inc.)
Laboratory Corporation of America Holdings, 1120 Main Street,
Southaven, MS 38671. 866-827-8042/800-233-6339. (Formerly: LabCorp
Occupational Testing Services, Inc.; MedExpress/National Laboratory
Center.)
Marshfield Laboratories, Forensic Toxicology Laboratory, 1000 North Oak
Ave., Marshfield, WI 54449. 715-389-3734/800-331-3734.
MAXXAM Analytics Inc.,* 6740 Campobello Road, Mississauga, ONT, Canada
L5N 2L8. 905-817-5700. (Formerly: NOVAMANN (Ontario), Inc.)
MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112
651-636-7466/800-832-3244.
MetroLab-Legacy Laboratory Services, 1225 NE 2nd Ave., Portland, OR
97232. 503-413-5295/800-950-5295.
Minneapolis Veterans Affairs Medical Center, Forensic Toxicology
Laboratory, 1 Veterans Drive, Minneapolis, MN 55417. 612-725-2088.
National Toxicology Laboratories, Inc., 1100 California Ave.,
Bakersfield, CA 93304. 661-322-4250/800-350-3515.
One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena,
TX 77504. 888-747-3774. (Formerly: University of Texas Medical Branch,
Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory.)
Oregon Medical Laboratories, P.O. Box 972, 722 East 11th Ave., Eugene,
OR 97440-0972. 541-687-2134.
Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA
91311. 800-328-6942. (Formerly: Centinela Hospital Airport Toxicology
Laboratory.)
Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane,
WA 99204. 509-755-8991/800-541-7897x7.
Physicians Reference Laboratory, 7800 West 110th St., Overland Park, KS
66210. 913-339-0372/800-821-3627.
Quest Diagnostics Incorporated, 3175 Presidential Dr., Atlanta, GA
30340. 770-452-1590/800-729-6432. (Formerly: SmithKline Beecham
Clinical Laboratories; SmithKline Bio-Science Laboratories).
Quest Diagnostics Incorporated, 4770 Regent Blvd., Irving, TX 75063.
800-824-6152. (Moved from the Dallas location on 03/31/01; Formerly:
SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science
Laboratories).
Quest Diagnostics Incorporated, 4230 South Burnham Ave., Suite 250, Las
Vegas, NV 89119-5412. 702-733-7866/800-433-2750. (Formerly: Associated
Pathologists Laboratories, Inc.)
Quest Diagnostics Incorporated, 10101 Renner Blvd., Lenexa, KS 66219.
913-888-3927/800-873-8845. (Formerly: LabOne, Inc.; Center for
Laboratory Services, a Division of LabOne, Inc.)
Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403.
610-631-4600/877-642-2216. (Formerly: SmithKline Beecham Clinical
Laboratories; SmithKline Bio-Science Laboratories).
Quest Diagnostics Incorporated, 506 E. State Pkwy., Schaumburg, IL
60173. 800-669-6995/847-885-2010. (Formerly: SmithKline Beecham
Clinical Laboratories; International Toxicology Laboratories).
Quest Diagnostics Incorporated, 7600 Tyrone Ave., Van Nuys, CA 91405.
818-989-2520/800-877-2520. (Formerly: SmithKline Beecham Clinical
Laboratories).
Quest Diagnostics Incorporated, 2282 South Presidents Drive, Suite C,
West Valley City, UT 84120. 801-606-6301/800-322-3361. (Formerly:
Northwest Toxicology, a LabOne Company; LabOne, Inc., dba Northwest
Toxicology; NWT Drug Testing, NorthWest Toxicology, Inc.; Northwest
Drug Testing, a division of NWT Inc.)
S.E.D. Medical Laboratories, 5601 Office Blvd., Albuquerque, NM 87109,
505-727-6300/800-999-5227.
South Bend Medical Foundation, Inc., 530 N. Lafayette Blvd., South
Bend, IN 46601. 574-234-4176 x276.
Southwest Laboratories. 4645 E. Cotton Center Boulevard, Suite 177,
Phoenix, AZ 85040. 602-438-8507/800-279-0027.
Sparrow Health System, Toxicology Testing Center, St. Lawrence Campus,
1210 W. Saginaw, Lansing, MI 48915. 517-364-7400. (Formerly: St.
Lawrence Hospital & Healthcare System).
St. Anthony Hospital Toxicology Laboratory, 1000 N. Lee St., Oklahoma
City, OK 73101. 405-272-7052.
Toxicology & Drug Monitoring Laboratory, University of Missouri
Hospital & Clinics, 301 Business Loop 70 West, Suite 208, Columbia, MO
65203. 573-882-1273.
Toxicology Testing Service, Inc., 5426 N.W. 79th Ave., Miami, FL 33166.
305-593-2260.
US Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St.,
Fort George G. Meade, MD 20755-5235. 301-677-7085.
*The Standards Council of Canada (SCC) voted to end its Laboratory
Accreditation Program for Substance Abuse (LAPSA) effective May 12,
1998. Laboratories certified through that program were accredited to
conduct forensic urine drug testing as required by U.S. Department of
Transportation (DOT) regulations. As of that date, the certification of
those accredited Canadian laboratories will continue under DOT
authority. The responsibility for conducting quarterly performance
testing plus periodic on-site inspections of those LAPSA-accredited
laboratories was transferred to the U.S. HHS, with the HHS' NLCP
contractor continuing to have an active role in the performance testing
and laboratory inspection processes. Other Canadian laboratories
wishing to be considered for the NLCP may apply directly to the NLCP
contractor just as U.S. laboratories do.
Upon finding a Canadian laboratory to be qualified, HHS will
recommend that DOT certify the laboratory (Federal Register, July 16,
1996) as meeting the minimum standards of the Mandatory Guidelines
published in the Federal Register on April 13, 2004 (69 FR
[[Page 1550]]
19644). After receiving DOT certification, the laboratory will be
included in the monthly list of HHS-certified laboratories and
participate in the NLCP certification maintenance program.
Anna Marsh,
Director, Office Program Services, SAMHSA.
[FR Doc. E6-96 Filed 1-9-06; 8:45 am]
BILLING CODE 4162-20-P
